Shortage of Bile acid sequestrants: colestyramine powder for oral suspension 4g (Questran), and colestipol (Colestid)

Yuet Wan, Medicines Information Pharmacist, London and South East Regional Medicines InformationSource London and South East Regional Medicines InformationPublished

Bristol-Myers Squibb divested the Questran range to Cheplapharm at the end of July 2019. This affected the availability of several bile acid sequestrants. The current stock situation is as follows:

  • Questran (Cheplapharm) – out of stock; resupply expected third quarter 2021Questran Light (Cheplapharm) – in stock

    Colestyramine light 4g sachets – Mylan – in stock

    Cholestagel (colesevelam) 625mg tablets (Sanofi) – in stock

    Colestid (colestipol) plain (Pfizer) – out of stock, with resupply date to be confirmed

    Colestid (colestipol) Orange (Pfizer) – out of stock until end of May 2021

This memo advises on management options for those products still out of stock.

Attachments